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the peculiarities of the nature of airway inflammation by the
study of the characteristics of the cellular structure of induced
sputum in school-age children with bronchial asthma with
early and late onset.
Materials and methods. There has been examined 46 school
age children suffering from persistent bronchial asthma. A
cytological analysis of induced by inhalation of hypertonic
solutions (3%, 5%, 7%) of sodium chloride sputum has been
performed by the method of Pavord I.D. in the modification of
Pizzichini M.M. (1996). Into the first (I) clinical group 21 child
with early onset of bronchial asthma (up to 3 years) has been
gotten, the second (II) group has been consisted of 25 children
with a late debut (at 6 years and later) of the disease.
Results. The cellular composition of the induced sputum
of children of I clinical group was: eosinophilic granulocytes
3,95±1,3%, neutrophilic granulocytes 49,9±4,1%, mast cells
0,38±0,3%, alveolar macrophages 30,0±4,5%, lymphocytes
15,8±2,9%, epithelial cells 47,8±4,7%. In the cytogram of
bronchial secretions in patients with late onset asthma there
have been included, respectively: eosinophils 14,2±4,3%
(P<0,05), neutrophils 46,3±4,8% (P>0,05), mast cells 0,5±0,3%
(P>0,05), macrophages, 29,7±4,5% (P>0,05), lymphocytes
9,3±2,8% (P>0,05) and epithelial cells 40,4±3,2% (P>0,05).
Conclusions. On the basis of a complex investigation of
46 children suffering from bronchial asthma, it has been stated
that early-onset disease characterized by a more expressive
damage of the epithelial layer of the airways due to their
neutrophil-lymphocytic inflammation, and in patients with
late-onset asthma phenotype the eosinophil-macrophagal
variant of inflammatory response in the bronchi has been
determined.
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Purpose of the study: To increase the effectiveness of
the basic therapy with the use of Nucleinat in its complex for
the treatment of school-age children’s bronchial asthma (BA).
Material and Methods: 98 school-age children with BA in the
period of remission were examination with a double blind,
randomized, placebo controlled method. All the patients were
divided into two groups. Patients of I group were administered
Nucleinat in the basic therapy, the second – placebo with the
same scheme. Bronchial hypersensitivity (BHS) was estimated
by the findings of PC20H and PD20Í. It was calculated the
absolute risk (AR), relative risk (RR) and odds ratio (OR)
realisation of event at the 1st group children to control group
with them 95% CI. The effectiveness of the basic treatment
was analyzed with next indexes: decrease of absolute risk
(DAR), relative risk (DRR) and the minimum number of the
patient which should be treated to have one positive result
(MNP). Results. Children in I group after the treatment were
characterized by higher risk reduction BHS relatively to
second. The relative risk of the positive change of BHS in I
group was 1,9 (95% CI 1,3-9,3), the absolute risk – 0,3 with
odds ratio – 3,3 (95% CI 1,7-6,1). Under the influence of
Nucleinat in the basic therapy revealed lowering of absolute
risk of distinct BHS and could see 25,8%, DRR – 54,8% (95%
CI 44,5-64,8) and MNP was equal to 1,8 (95% CI 0,1-7,1).
Conclusions. The use of Nucleinat in the combined therapy
for children’s BA ensures a significant reduction in BHS. The
inclusion of Nucleinat in the basic therapy led to an increase
the effectiveness of BA treatment in every second patient.
Summary. The effect of Nucleinat included in the basic
therapy of BA has been analyzed by means of double-blind,
placebo-controlled method in 98 school age children. The
application of the Nucleinat in complex therapy of the BA
was accompanied by decrease of BHS due to the possible
reduction of the inflammatory process activity in the airways.
The use of Nucleinat in the basic therapy of the school-age
children led to an increase the effectiveness of BA treatment
in every second patient.
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Timeliness: obesity refers to one of the most widespread
endocrine-metabolic diseases among children and
adolescents.
Goal of research: to study the occurrence of main
components of metabolic syndrome among children and
adolescents with obesity for early detection of high-risk
groups and prevention program development.
Materials and methods. we have analyzed 797 medical
records of school-aged inpatients proceeding with the
treatment for obesity in endocrinology department of regional
children’s clinical hospital as of from 2005 to 2008.
Outcomes: Among 797 school-aged children (444 boys
and 353 girls of 7-17 years old) the final diagnosis was:
pubertate dyspituitarism with impaired fat metabolism of one
degree or another in 87,0 % cases, constitutive exogenous
obesity in 12,5 % cases and Laurence-Moon-Biedl-Bardet
syndrome in 4 children. The first degree obesity was
diagnosed in 12,0%, the second degree was diagnosed in
